Goodwin Advises Ollin Biosciences on Oversubscribed $330 Million Series B Financing
June 24, 2026
June 24, 2026
BOSTON, Massachusetts, June 24 [Category: BizLaw/Legal] -- Goodwin, a law firm, posted the following news release:
* * *
Goodwin Advises Ollin Biosciences on Oversubscribed $330 Million Series B Financing
*
The Life Sciences team advised Ollin Biosciences, Inc., (Ollin) on an oversubscribed $330 million Series B financing. The financing round was co-led by new investor TCGX and founding investor ARCH Venture Partners, with participation from a . . .
* * *
Goodwin Advises Ollin Biosciences on Oversubscribed $330 Million Series B Financing
*
The Life Sciences team advised Ollin Biosciences, Inc., (Ollin) on an oversubscribed $330 million Series B financing. The financing round was co-led by new investor TCGX and founding investor ARCH Venture Partners, with participation from a . . .